OpiCalc Logo

OpiCalc

989 Clinical Tools

Logo
OpiCalc
ABC-AF Bleeding ScoreABC-AF Stroke ScoreABCD2 ScoreADD-RSAortic Valve Calcium ScoreAPPLE ScoreASCVD (Pooled Cohort)AVA (Continuity Equation)BAG-AHF ScoreBiplane Simpson EFBlood Pressure PercentilesBrugada Criteria (VT vs SVT)Cardiac Output IndexCHA2DS2-VAScCHADS2Cornell Voltage CriteriaCRUSADE Bleeding ScoreDAPT ScoreDASIDuke Treadmill ScoreE/A RatioEDACS ScoreEHMRGEHRA ScoreEmbolic Risk ScoreEROA (PISA Method)FFR (Fractional Flow Reserve)Fick Cardiac OutputFramingham 10-Year RiskFriedewald LDL EquationGorlin EquationGRACE ScoreGupta MICA (NSQIP)GWTG-HF ScoreH2FPEF ScoreHakki FormulaHAS-BLEDHEART PathwayHEART ScoreHEMORR2HAGEShs-Troponin 0h/1h ESC AlgorithmiFRINTERCHEST ScoreKillip ClassificationLee's RCRILV Mass IndexLV Stroke Work IndexMAGGIC Risk ScoreMAP CalculatorMartin/Hopkins LDLModified Duke CriteriaModified Sgarbossa CriteriaMVA (Pressure Half-Time)Non-HDL CholesterolNT-proBNP Age-Adjusted ThresholdsORBIT ScoreOttawa Heart Failure RiskPulse PressurePVR CalculatorPVR IndexQRISK3QTc (Bazett)QTc (Fridericia)REVEAL 2.0 ScoreREVEAL Lite 2Reynolds Risk ScoreROSIRVSP CalculatorSchwartz Score (LQTS)SCORE2Seattle Heart Failure Model (SHFM)Sgarbossa CriteriaShock IndexSokolow-Lyon VoltageStroke Volume IndexSVR CalculatorSYNTAX ScoreSYNTAX Score IITAPSETeichholz FormulaTIMI (STEMI)TIMI (UA/NSTEMI)Troponin Delta CalculatorValvular GradientsVancouver Chest Pain RuleVereckei AlgorithmWATCHDM ScoreWilkins ScoreWood Units Calculator
OpiCalc Logo

OpiCalc

Open-access clinical infrastructure. Built to the standard every clinician deserves — fast, private, and free.

Zero data stored
Always free
Our mission & transparency

Get in Touch

Tool request, clinical feedback, or partnership inquiry — we read everything.

WhatsApp feedback
Email us
Partnership inquiry

© 2026 OpiCalc • Calculated Care

ProtocolsAboutPrivacyTerms

LV Mass Index

Echocardiographic LV Mass Estimator • Devereux et al.

IVS (mm)
LV Int. Dia. (mm)
Post. Wall (mm)
BSA (m²)

Ready for Dimensions

Input echocardiographic measurements to determine LV hypertrophy severity.

Guidelines & Evidence

Clinical Details

Section 1

When to Use

When to Use

Assessment of Left Ventricular Hypertrophy (LVH) in newly diagnosed or refractory hypertensive patients.
Monitoring the reversal of LVH in response to intensive antihypertensive or structural (valvular) therapy.
Risk stratification in patients with subclinical target organ damage.
Differentiation between physiologic hypertrophy (athlete's heart) and pathologic remodeling.
Section 2

Formula & Logic

Devereux Formula

LVM = 0.8 × (1.04 × ((IVST + LVID + PWT)³ - LVID³)) + 0.6 LVMI = LVM / Body Surface Area (BSA)

ASE Guideline Thresholds (g/m²)

SeverityFemaleMale
Normal43 - 9549 - 115
Mildly Abnormal96 - 108116 - 131
Moderately Abnormal109 - 121132 - 148
Severely Abnormal≥ 122≥ 149
Section 3

Pearls/Pitfalls

Indexing Limitations

In obese patients, standard indexing by BSA may underestimate the severity of LVH because excess adipose tissue bloats the denominator. Consider indexing to height (m^2.7) or utilizing Body Fat Percentage distributions instead.
M-mode heavily relies on geometric assumptions (that the ventricle is a prolate ellipse). If shape is significantly distorted (e.g. basal septal bulge or asymmetric remodeling), 3D echocardiography or Cardiac Magnetic Resonance (CMR) offers significantly improved accuracy.
Age and gender independently impact normal ranges. While Japanese and American cohorts show no racial variations in 3DE studies, significant divergence still occurs strictly by biological sex.
Section 4

Evidence Appraisal

Primary References

Normal Values of Left Ventricular Mass Index Assessed by Transthoracic Three-Dimensional Echocardiography.

Mizukoshi K et al. • J Am Soc Echocardiogr.. 2016;Demonstrated superior accuracy of 3DE vs CMR for LV mass quantification, confirmed age/gender dependence, and ruled out ethnic variability between Japanese and American patient populations. https://doi.org/10.1016/j.echo.2015.09.009

The relationship between left ventricular mass index and body composition in new-diagnosed hypertensive patients.

Karakan S et al. • Clin Hypertens.. 2015;Proved independent association of Body Fat Percentage (BFP) and higher LVMI in normotensive to newly hypertensive patients. Strongly advocates correcting for adipose influence. https://doi.org/10.1186/s40885-015-0033-6

Last Comprehensive Review: 2026

Related Cardiovascular Tools

Cornell Voltage Criteria
E/A Ratio
Sokolow-Lyon Voltage
GRACE Score
Gupta MICA
GWTG-HF Score
H2FPEF Score
Hakki Formula
HAS-BLED
HEART Pathway
Have feedback about this calculator?Let us know.